B. BRAUN MELSUNGEN AG Overview
Established in 1839 and headquartered in Germany, B.Braun is a leading healthcare supplier. The company provides its products for hospitals, surgeries, private practices (medical care and doctors´ offices), and extracorporeal blood treatments. The company’s product segments include clinical nutrition, urinary care, infection prevention, insulin therapy, diabetes care, neurosurgery, extracorporeal blood treatment, IV drugs, orthopaedics, spine, and wound care, amongst others. B.Braun operates in four major divisions, namely, Hospital Care, Aesculap, Out Patient Market, and B. Braun Avitum. With these four divisions, the company has a wide range of products with about 5,000 products, out of which 95% of the products are manufactured by the company.
Geographically the company operates in 64 countries in regions such as Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The company generated a revenue of about USD 6672 million in 2015 with a head count of more than 55,000 employees all around the globe.



